Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Syngene plans $100 mn manufacturing facility in Mangalore

The contract research & manufacturing company is in process of acquiring 40 acres land for the facility at Mangalore SEZ, Karnataka

BS B2B Bureau  |  Mumbai 

Syngene International's Bangalore facility
Syngene International’s Bangalore facility

International, the subsidiary of engaged in contract research, is reportedly planning to spend $ 100 million (about Rs 664 crore) for setting up a new manufacturing plant at Mangalore SEZ, Karnataka. The company said that it is in process of acquiring 40 acres land for the facility and anticipates to complete the detailed engineering for the proposed project in the first half of 2016.
 
Confirming this in a BSE filing on August 31, 2015, said, “The company is planning to set up a new manufacturing facility at and is in the process of acquiring 40 acres of land and obtaining necessary approvals. The estimated expenditure for setting up the facility is $ 100 million and is contingent of various factors. We will intimate the exchanges with appropriate details in the 1st half of 2016 after completing the detailed engineering for the proposed project."
 
The expansion announcement follows International’s successful listing on BSE & NSE on August 11, 2015.
 
Syngene is one of the leading custom research and manufacturing organisations, offering a suite of integrated, end-to-end discovery and development services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.

First Published: Tue, September 01 2015. 13:02 IST
RECOMMENDED FOR YOU

Syngene plans $100 mn manufacturing facility in Mangalore

The contract research & manufacturing company is in process of acquiring 40 acres land for the facility at Mangalore SEZ, Karnataka

The contract research & manufacturing company is in process of acquiring 40 acres land for the facility at Mangalore SEZ, Karnataka International, the subsidiary of engaged in contract research, is reportedly planning to spend $ 100 million (about Rs 664 crore) for setting up a new manufacturing plant at Mangalore SEZ, Karnataka. The company said that it is in process of acquiring 40 acres land for the facility and anticipates to complete the detailed engineering for the proposed project in the first half of 2016.
 
Confirming this in a BSE filing on August 31, 2015, said, “The company is planning to set up a new manufacturing facility at and is in the process of acquiring 40 acres of land and obtaining necessary approvals. The estimated expenditure for setting up the facility is $ 100 million and is contingent of various factors. We will intimate the exchanges with appropriate details in the 1st half of 2016 after completing the detailed engineering for the proposed project."
 
The expansion announcement follows International’s successful listing on BSE & NSE on August 11, 2015.
 
Syngene is one of the leading custom research and manufacturing organisations, offering a suite of integrated, end-to-end discovery and development services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.
image
Business Standard
177 22

Syngene plans $100 mn manufacturing facility in Mangalore

The contract research & manufacturing company is in process of acquiring 40 acres land for the facility at Mangalore SEZ, Karnataka

International, the subsidiary of engaged in contract research, is reportedly planning to spend $ 100 million (about Rs 664 crore) for setting up a new manufacturing plant at Mangalore SEZ, Karnataka. The company said that it is in process of acquiring 40 acres land for the facility and anticipates to complete the detailed engineering for the proposed project in the first half of 2016.
 
Confirming this in a BSE filing on August 31, 2015, said, “The company is planning to set up a new manufacturing facility at and is in the process of acquiring 40 acres of land and obtaining necessary approvals. The estimated expenditure for setting up the facility is $ 100 million and is contingent of various factors. We will intimate the exchanges with appropriate details in the 1st half of 2016 after completing the detailed engineering for the proposed project."
 
The expansion announcement follows International’s successful listing on BSE & NSE on August 11, 2015.
 
Syngene is one of the leading custom research and manufacturing organisations, offering a suite of integrated, end-to-end discovery and development services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.

image
Business Standard
177 22